“Serious Faults” In Novartis Pharma K.K. Clinical Study Of Leukemia Drug: Panel

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

TOKYO (Kyodo) -- Novartis Pharma K.K. violated Japan's personal information protection law and ethical guidelines in a clinical study, led by the University of Tokyo, of a leukemia drug, the university's investigation panel said Tuesday.

Following release of its final report, the university will consider punishing those responsible, a university official said.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC